GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xebra Brands Ltd (XCNQ:XBRA) » Definitions » EV-to-EBIT

Xebra Brands (XCNQ:XBRA) EV-to-EBIT : -2.24 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xebra Brands EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Xebra Brands's Enterprise Value is C$5.36 Mil. Xebra Brands's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was C$-2.39 Mil. Therefore, Xebra Brands's EV-to-EBIT for today is -2.24.

The historical rank and industry rank for Xebra Brands's EV-to-EBIT or its related term are showing as below:

XCNQ:XBRA' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.05   Med: -0.95   Max: -0.2
Current: -2.24

During the past 4 years, the highest EV-to-EBIT of Xebra Brands was -0.20. The lowest was -3.05. And the median was -0.95.

XCNQ:XBRA's EV-to-EBIT is ranked worse than
100% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.955 vs XCNQ:XBRA: -2.24

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Xebra Brands's Enterprise Value for the quarter that ended in Nov. 2023 was C$1.29 Mil. Xebra Brands's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was C$-2.39 Mil. Xebra Brands's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 was -185.74%.


Xebra Brands EV-to-EBIT Historical Data

The historical data trend for Xebra Brands's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xebra Brands EV-to-EBIT Chart

Xebra Brands Annual Data
Trend Feb20 Feb21 Feb22 Feb23
EV-to-EBIT
- - -6.03 -1.04

Xebra Brands Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.56 -1.04 -1.15 -0.27 -0.54

Competitive Comparison of Xebra Brands's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Xebra Brands's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xebra Brands's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xebra Brands's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Xebra Brands's EV-to-EBIT falls into.



Xebra Brands EV-to-EBIT Calculation

Xebra Brands's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.364/-2.392
=-2.24

Xebra Brands's current Enterprise Value is C$5.36 Mil.
Xebra Brands's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xebra Brands  (XCNQ:XBRA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Xebra Brands's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Nov. 2023 ) =EBIT / Enterprise Value (Q: Nov. 2023 )
=-2.392/1.287789
=-185.74 %

Xebra Brands's Enterprise Value for the quarter that ended in Nov. 2023 was C$1.29 Mil.
Xebra Brands's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xebra Brands EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Xebra Brands's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Xebra Brands (XCNQ:XBRA) Business Description

Traded in Other Exchanges
Address
1090 Hamilton Street, Vancouver, BC, CAN, V6B 2R9
Xebra Brands Ltd is focused on cannabis cultivation and products, with global brands and intellectual property. Its products cover wellness and leisure and include beverages. It has one reportable business segment, being the cultivation, processing, manufacturing, design and delivery of cannabis products.

Xebra Brands (XCNQ:XBRA) Headlines

No Headlines